2011
DOI: 10.1177/153303461101000605
|View full text |Cite
|
Sign up to set email alerts
|

Using In-Vivo Fluorescence Imaging in Personalized Cancer Diagnostics and Therapy, an Image and Treat Paradigm

Abstract: The major goal in developing drugs targeting specific tumor receptors, such as Monoclonal AntiBodies (MAB), is to make a drug compound that targets selectively the cancer-causing biomarkers, inhibits their functionality, and/or delivers the toxin specifically to the malignant cells. Recent advances in MABs show that their efficacy depends strongly on characterization of tumor biomarkers. Therefore, one of the main tasks in cancer diagnostics and treatment is to develop non-invasive in-vivo imaging techniques f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 30 publications
(13 citation statements)
references
References 74 publications
0
13
0
Order By: Relevance
“…In the latter case, optical monitoring of drug release can be achieved by triggering not only the release (i.e., binding to the cell surface receptor) but also a fluorescent marker (29,30). Another approach for imaging and treating at the same time is using fluorescence lifetime for tumor receptor quantification (31). However, in this case, treatment is not achieved simultaneously with imaging.…”
mentioning
confidence: 99%
“…In the latter case, optical monitoring of drug release can be achieved by triggering not only the release (i.e., binding to the cell surface receptor) but also a fluorescent marker (29,30). Another approach for imaging and treating at the same time is using fluorescence lifetime for tumor receptor quantification (31). However, in this case, treatment is not achieved simultaneously with imaging.…”
mentioning
confidence: 99%
“…The higher uptake at the tumor site indicates its higher vascularization. The fluorescence intensity at the tumor and contralateral sites was normalized to the background intensity of the tumor area before injection (after [147]).…”
Section: Non-targeted Fluorescent Probesmentioning
confidence: 99%
“…Optical imaging techniques have high potential in this application due to the ability for real-time noninvasive monitoring of the efficiency of photodynamic reaction in combination with compactness and economic efficacy. [23][24][25] Most of the studies employ fluorescence imaging (FI) allowing one to evaluate PS accumulation level, monitor PS photobleaching, and clarify the tumor border in oncologic applications. [26][27][28][29][30] Combination of FI with spectroscopy techniques allows for simultaneous monitoring of singlet oxygen production in the course of PDT procedure.…”
Section: Introductionmentioning
confidence: 99%